The core structure of the complex pentacyclic 5,11-methanomorphanthridine skeleton and the vicinal quaternary and tertiary stereocenters of the 5,10b-phenanthridine skeleton are constructed stereospecifically in one step employing intramolecular 1,3-dipolar cycloaddition of a nonstabilized azomethine ylide (AMY) generated by the sequential double desilylation of appropriate bis-trimethylsilylmethyl amines using Ag(I)F as a single-electron oxidant. The strategy is successfully applied for the total synthesis of biologically active alkaloids such as (±)-pancracine, (±)-brunsvigine, (±)-maritidine, and (±)-crinine.
INTRODUCTION
Alkaloids isolated from plants of the Amaryllidaceae [1] [2] [3] [4] family are endowed with a variety of physiological activities [5, 6] such as antitumor, antiviral, acetylcholinesterase (AChE) inhibitory, immunostimulatory, antimalarial, anxiolytic, antidepressive, anticonvulsive, and weak hypotensive activity and have long been a source of structurally intriguing target molecules that challenge the capabilities of contemporary organic synthesis. Amaryllidaceae alkaloids are classified into 18 subgroups on the basis of their structural frameworks of which montanine type (1), crinine type (2), lycorine type (3), and pancratistatine type (4) are a few important examples (Fig. 1) .
While the crinine class of alkaloids possesses a phenanthridine skeleton with a fused tetracyclic skeleton displaying adjacent quaternary and tertiary carbon stereocenters, the montanine class is based on a unique linearly fused pentacyclic 5,11-methanomorphanthridine skeleton (Fig. 2) . A major challenge in devising a synthetic strategy for these alkaloids is stereocontrolled incorporation of the fused pyrrolidine ring system in a polycyclic structural framework. Although a few elegant synthetic strategies are known, an efficient and conceptually new route has remained elusive. In this context, we became interested in the scope of exploiting our strategy for stereospecific assembly of substituted pyrrolidine ring systems by [3 + 2] -cycloaddition of a nonstabilized azomethine ylide (AMY), generated by sequential double desilylation of N,N'-bis(trimethylsilylmethyl)alkyl amines [7] for the construction of the core structure of these alkaloids.
(2.5 equiv) in dry CH 3 CN at room temperature (rt). Chromatographic purification of the crude mass gave expected tetracyclic core 23 of the 5,11-methanomorphanthridine in 65 % yield. The relative stereo chemistry of 23 was confirmed by 2D NMR studies.
Enthused by the success of the concept, we proceeded with the proposed synthesis of the montanine type of alkaloids through this strategy.
FORMAL TOTAL SYNTHESIS OF (±)-PANCRACINE
Initially, we focused our attention on synthesizing 10, an advanced intermediate utilized by Overman et al. [15] in the total synthesis of the (±)-pancracine (1a), by the intramolecular cycloalkylation of 14. The cycloaddition precursor 13 was prepared (60 % yield) by the Heck coupling of 14 with the methyl vinyl ketone (MVK, 8 equiv). Synthesis of 13 was achieved in 81 % yield by the N-alkylation of 16 with 15 in refluxing CH 3 CN in the presence of activated K 2 CO 3 followed by simple benzoylation of the primary hydroxyl group. The bis-silyated secondary amine 16 was synthesized (61 % overall yield) easily from 3-propan-1-ol (24) as shown in Scheme 3.
The intramolecular cycloaddition of AMY 12, generated from 13 by following the standard cycloaddition protocol, gave 11 (56 % isolated yield) as a single diastereoisomer (Scheme 6). The stereo chemical assignments of 11 were made by extensive correlation spectroscopy (COSY), nuclear Overhauser spectroscopy (NOESY), and heteronuclear correlation (HETCOR) NMR spectral studies [23] . With fused tetracyclic 11 in hand, the only task toward completing the formal synthesis of 1a remained the construction of the E-ring through a cycloalkylation strategy. While debenzoylation of 11 by stirring with LiOH/MeOH at rt resulted in an unexpected epimerized alcohol 30 in 98 % yield (confirmed by X-ray crystallography) [24] , reaction at 0 °C gave 29 (Scheme 4). Since C11a stereochemistry at this stage was irrelevant toward accomplishing the synthesis of final natural product, we continued further with 30 itself. Cycloalkylation attempt from corresponding mesylate derivative of 30 using lithium diisopropylamide/tetrahydrofuran (LDA/THF) [25] at -78 °C, surprisingly, produced rearranged 34 (65 % yield), possibly involving thermodynamic enolate 32 (Scheme 5) as an intermediate. This unexpected result led us to explore an alternative strategy of generating kinetic enolate from 30 using potassium bis(trimethylsilyl)amide (KHMDS)/THF [26] at -78 °C, which produced expected cyclized product 33 (11a-epi-10) in 58 % yield. In order to complete the formal total synthesis of 1a, After accomplishing the synthesis of 35 [8] , an advanced intermediate used by Overman's group [15] in the synthesis of 1a, we realized the limitation of this approach for the synthesis of other members of this class of alkaloids. Therefore, we turned our attention to designing a general route for the synthesis of other alkaloids of this class. Since there are variety of oxygen substituents at C-2 and C-3 in the E-ring, we envisioned 36 as an ideal precursor as its olefinic moiety could be useful for installing various oxygen functionalities stereoselectively. The synthesis of 36 was visualized either by an intramolecular aldol reaction of 37 or by Howards-Wadsworth-Emmons (HWE) olefination of 38 (Scheme 6). At first, we initiated the synthesis of 36 through an intramolecular Mukaiyama-type aldol reaction [29] of 37, synthesized in 51 % yield by the usual cycloaddition reaction using appropriate substrate, by treating with trimethylsilyl trifluoromethanesulfonate (TMSOTf) (2 equiv) in the presence of 2,6-lutidine (3 equiv) in THF at -20 °C [30] which, unfortunately, gave an unexpected compound whose structure was tentatively assigned as 40. This unanticipated failure also prompted us to evaluate the classical acid/base-catalyzed intramolecular aldol reaction [31] from the unmasked aldehyde obtained from 37. Toward this end, deprotection of the dioxolane moiety of 37 was attempted initially under mild reaction conditions, viz.: (a) PPh 3 , CBr 4 , THF, 0 °C [32] ; (b) dichlorodicyano-p-benzoquinone (DDQ), CH 3 CN:H 2 O (9:1), rt [33] ; (c) TMSI, CH 3 CN [34] , however, none of the above-mentioned reaction conditions produced anticipated aldehyde. Surprised with these observations, we stirred 37 with 3N HCl in THF-H 2 O (1:1) at rt, which also, unfortunately, produced an epimerized 41 and not the expected aldehyde. The structure of 41 was elucidated by detailed spectral analyses and confirmed by singlecrystal X-ray crystallography [35] . Ultimately, deprotection of dioxolane moiety was achieved producing 42, presumably involving 41, in moderate yield (56 %) by refluxing 37 with 3N HCl for 10 h. Our entire attempt to transform 47 to corresponding aldol product under various acidic/basic conditions, however, again failed [31] . Therefore, we abandoned this route.
With these unanticipated hurdles, we envisioned to obtain 36 by intramolecular HWE reaction [36] of a corresponding aldehyde obtained from β-ketophosphonate 38, synthesized (92 % yield) by the reaction of the lithium salt of the diethyl methylphosphosphonate on 43. Similar to earlier observations, here also our attempt to deprotect dioxalone moiety of 38 to produce corresponding aldehyde under a variety of reaction conditions such as 3N HCl/THF-H 2 O, oxalic acid/THF-H 2 O failed, and it produced a rearrangement product identified as 44 (68 % yield) along with some other unidentified compounds (Scheme 8).
Mechanistically, this rearrangement was rationalized by invoking the thermodynamic enol-ether 46 followed by rearrangement either via Gröb-type fragmentation [37] or by involving azetidium salt intermediate 50 as shown in Scheme 9. Therefore, it may be concluded that during deprotection of the dioxolane moiety from both 37 as well as 38 either rearranges from five-to seven-membered ring to relieve strain or reaction stops at 41 with the epimerization at C11a center, which probably does not allow the cyclic enone 39 to be formed as it would lead to a conformationally strained system having three sp 2 carbons in the E-ring with "anti" stereochemistry at C11a and C4a.
With the above disappointing results and conclusion in mind, we proceeded to install C 2 =C 3 double bond by ring-closing metathesis (RCM) of 56, easily obtainable from 43 as shown in Scheme 10. Acetal moiety of 43 was deprotected by heating with oxalic acid/THF-H 2 O (1:1), and corresponding aldehyde was subsequently subjected to one-carbon Wittig olefination using benzylidenetriphenylphosphorane (equivalent to one carbon Wittig) to obtain 52 in 60 % yield. Reduction of 52 first to alcohol 53 (96 % yield) using DIBAL-H (2.2 equiv) in dry dichloromethane (DCM) at -78 °C followed by standard Swern oxidation gave corresponding 54 quantitatively. Aldehyde 54 was straightway treated with vinylmagnesium bromide (1 M solution in THF) at 0 °C to produce 55 quantitatively as a mixture of two diastereomers. At this stage, exact diastereomeric ratios could not be ascertained; therefore, hydroxyl group of 55 was protected as acetate 56 by employing standard protocol [Ac 2 O/TEA/DMAP (cat.)] and established the diastereomeric ratio as 2.5:1.
As per our planned strategy, the mixture of both of the diastereomers of 56 was forwarded to RCM utilizing original Grubb's reaction condition employing either first or second-generation [38] cat-ments gave primarily starting material back even after 2-3 days. Finally, the reaction using Grubb's second-generation catalyst with 56.HCl salt in DCM at 40 °C produced corresponding cyclized products 57:58 (2.5:1) in 93 % yield. Both these diastereomers (57 and 58) were isolated pure by flash column chromatography and were characterized by 1 H and 13 C NMR spectral analyses. The C 1 -OAc stereochemistry for both the diastereomers was assigned on the basis of the extensive COSY and NOESY NMR studies. The NOESY spectrum of 58 revealed the presence of NOE cross-peak between H 1 and H 4a , suggesting "syn" relative stereochemistry between each other (Fig. 4) and the acetoxy group being in the "endo" position.
At this stage, we realized the potential of both these diastereomers (57 and 58) for the synthesis of the target natural products by functional group interconversions by exploiting the stereochemistry of allylic acetoxy functionality to direct the hydroxylation of olefinic double bond. In this context, we attempted first the total synthesis of (±)-brunsvigine (1b), an important member of this class.
SYNTHESIS OF (±)-BRUNSVIGINE (1b)
In order to achieve the total synthesis of (±)-brunsvigine (1b), the major diastereomer 57 was subjected to dihydroxylation using OsO 4 /pyridine in t BuOH in the presence of trimethylamine N-oxide as a cooxidant and obtained 59 quantitatively as a white crystalline solid.
Compound 59 was transformed to 60 in 95 % yield by isopropylidine protection (2,2-dimethoxypropane/p-TSA) of the vicinal dihydroxyl groups before installing the pivotal Δ-double bond [25a,29] required to complete the total synthesis of 1b. Initially, dehydrogenative elimination of acetate moiety was attempted by using diazabicycloundecane (DBU) [39] at elevated temperature in benzene/toluene; however, it failed to yield the desired 62. Therefore, acetate moiety was deprotected and mesylated, which on refluxing with DBU for 2 days in toluene gave 62 in 89 % yield. Finally, to complete the synthesis of 1b, acetonide moiety was deprotected by passing HCl (gas) in its methanolic solution. For further purification and characterization, 1b.HCl was directly transformed into corresponding diacetate derivative 1b' (95 % yield) using acetic anhydride and triethylamine in presence of catalytic amount of N,N-dimethylaminopyridine (DMAP) (Scheme 11). The spectral data of compounds 62 as well as 1b' (diacetate derivative) were found to be in excellent agreement with the values reported in the literature [18] .
After successful synthesis of (±)-brunsvigine (1b), we visualized the scope of this strategy for the synthesis of other members of this class of alkaloids such as the (±)-pancracine (1a) and the (±)-montanine (16) from either one of the diastereomers (57 or 58) through the intermediate 64 as shown in Scheme 12. Toward transforming 57 to 64, it was envisaged that 63, obtained by acetate hydrolysis of either 57 or 58, can deliver epoxide 64 depending on the sequence of epoxidation. Compound 64 on treatment with either H 2 SO 4 /THF-H 2 O or BF 3 ؒOEt 2 /MeOH can produce either (±)-pancracine (1a) or (±)-montanine (1d), respectively [12] . addition of AMYs with a variety of alkenes has emerged as one of the most powerful strategy for the construction of enantiopure pyrrolidine ring systems [44, 45] , developing an asymmetric [3 + 2]-cycloaddition approach for assembling the 5,11-methanomorphanthridine structural framework appeared worth exploring as it would be an entirely new concept in this area.
In this regard, we designed our strategy from the same intermediate 65 and equipped it with the Evans' oxazolidinone chiral auxiliary (Scheme 13) by the Heck coupling of known 67 [46] and obtained 66 in 65 % yield. The cycloaddition of 66 gave corresponding cycloadduct, which was subjected to lithium aluminum hydride (LAH) reduction without purification and characterization and obtained 68 (46 % yield, ee, 63 %, after single crystallization) [47] . Compound 68 can now easily be converted to RCM products 57 and 58 through 56 as discussed earlier in Scheme 10.
CONSTRUCTION OF 5,10B-ETHANOPHENANTHRIDINE STRUCTURAL FRAMEWORK
The maritidine (2a) and its structural analogues, isolated from Pancratium maritimum, Pancratium tortuosum, and Zephyranthes genera, are the first alkaloids with the 5,10b-ethanophenanthridine nucleus (6) containing dimethoxy rather than methylenedioxy substituents at C-8 and C-9 positions of the crinine skeleton. These alkaloids exhibit a wide range of interesting physiological effects, including antitumor, antiviral, acetylcholinesterase inhibitory, immunostimulatory, and antimalarial activities. The crinine (2b) is of particular interest owing to its cytotoxic properties and limited supplies from natural sources. Structurally, these alkaloids possess fused tetracyclic skeletons displaying adjacent quaternary and tertiary carbon stereocenters with the fused pyrrolidine ring systems for which stereochemical incorporation is the critical element in their synthesis.
A number of synthetic efforts have been employed to solve the challenging problem of incorporating these sterically congested stereocenters into the 5,10b-ethanophenanthridine structural framework. In this context, intramolecular oxidative para-para phenolic coupling [59] , intramolecular ene cyclization [60] of an appropriately constructed acylnitroso olefin, or condensation of 3-arylated Δ1-pyrrolinium salts with the tert-butyl 3-oxopent-4-enoate [61] . A few other approaches reported for the synthesis of 2 have involved intramolecular cycloamination reactions from an appropriate spiro precursor for the carbon-nitrogen bond formation in the construction of the substituted angular phenanthridine skeleton (Fig. 5) [69] .
RETROSYNTHESIS
While designing a versatile route to the 5,10b-ethanophenanthridine alkaloids such as maritidine via oxomaritidine 72, we speculated the formation of C 1 -C 2 double bond by the cyclo-aldolization/condensation of corresponding δ-keto aldehyde 73, easily obtainable from 74. A serious evaluation of 74 structure revealed the presence of fused pyrrolidine ring (BD rings) with adjacent vicinal quaternary and tertiary stereocenters. Thus, it was presumed that an intramolecular [3 + 2]-cycloaddition of a nonstabilized AMY 75 with tethered geminally disubstituted dipolarophile would result in the formation of both C 4a -C 10b and C 11 -C 12 bonds in one step, generating required stereocenters of 72 in a single step. The corresponding AMY could be generated in situ from the corresponding α,α'-bis(trimethylsilylmethyl) alkyl amine 76 as shown in Scheme 14.
The requisite precursor 76 required for the key transformation was proposed to be synthesized from modified Stille coupling [70] of corresponding aryl iodide 77 and a suitable vinyl stannane 78 [71] . The aryl iodide 77 can be synthesized by alkylation of bis-silylalkyl amine ketal 79 and diiodo component 80. These components in turn may be obtained from commercially available veratryl alcohol (82) and MVK (81). Regio-as well as stereochemical issues, the two important aspects of this cycloaddition strategy, were evaluated at the planning stage of the synthesis itself. The origin of the 5,10b-ethanophenanthridine regiochemistry during cycloaddition was speculated on the basis of the change in the lowest unoccupied molecular orbital (LUMO) energy of the dipolarophile owing to its conjugation with the aromatic ring and ester moiety present on the same carbon. The cycloaddition reaction of 76 was visualized to generate the vicinal quaternary and tertiary carbon stereocenters in one step with the orientation of substituents in the dipole deciding the stereochemical outcome at C 4a position. For illustration, it was hypothesized that the alkyl ketal moiety in AMY (75a) may experience severe stereoelectronic congestion with the tethered aromatic ring flanked between the dipole and the dipolarophile as shown in transition state-I (TS-I) (Fig. 6 ) resulting in epimeric epi-4a-74. On the other hand, TS-II, in which the alkyl ketal side chain of AMY 75 and the aromatic ring are distantly away from each other, may generate the desired C 4a stereochemistry (74) . Thus, we anticipated that substrate-controlled stereoelectronic favor during cycloaddition of 75 would reinforce the stereochemical outcome in the tricyclic skeleton with suitable stereochemical disposition of the substituents required for assembling of the C-ring of the target alkaloid. 
SYNTHESIS OF (±)-MARITIDINE
Our synthesis started with the assembling of the key precursor 76, which involved coupling of 79 and 80 followed by Stille coupling with a suitably substituted vinyl stannane (78). Aromatic electrophilic iodination [72] of commercially available veratryl alcohol (82) with the iodine using silver trifluoroacetate as a Lewis acid afforded 83, which was converted to 80 in quantitative yield by treating with NaI and TMSCl in CH 3 CN at rt (Scheme 15).
The other component 79 was obtained by following the sequence as shown in Scheme 16. The N-Boc-protected amino butanol 84 was synthesized (70 % yield) in two steps starting from the commercially available MVK (81) and BocNH 2 . Refluxing a solution of 84 and acetaldehyde diethyl acetal in the presence of a catalytic amount of pyridinium p-toluenesulfonate (PPTS) in benzene, while azeotropic removal of ethanol, gave N-Boc protected cyclic amine 86 quantitatively. Treatment of 86 with s-BuLi/TMEDA at -78 °C in THF followed by the addition of TMSCl gave 87 in 85 % yield [73] . The amino acetal deprotection of 87 by stirring with p-TSA in MeOH gave corresponding amino alcohol 88 in quantitative yield, which upon oxidation using o-iodosoxybenzoic acid (IBX) in refluxing EtOAc produced 89 in 90 % yield. The ketalization of 89 by refluxing with the ethylene glycol and catalytic p-TSA in benzene, while azeotropic removal of the water, gave 90 in 80 % yield which on N-Boc cycloaddition of the AMY generated from 76 produced 74 as a yellow gummy liquid in 56 % yield. The stereochemical assignment of 74 was assigned by extensive COSY, NOESY, and HETCOR NMR studies (Scheme 18).
After successful synthesis and complete characterization of 74 with ABD ring, the next task toward the completion of the synthesis of the natural product remained the construction of ring C. In order to proceed further along the proposed synthesis, 74 was subjected to diisobutylaluminum (DIBAL) reduction. However, this reaction led to the reduction of ester functionality along with ketal deprotection presumably via coordination of alkoxy aluminum with ketal oxygen followed by the deprotection of ketal group to give stable hemiketal 96 (Scheme 19). Thus, we adopted a two-step protocol of reduction-oxidation involving LAH reduction of 74 followed by Swern oxidation, which gave 98 in 90 % yield. The deprotection of the ketal moiety of 98 using p-TSA in acetone followed by stir-ring with ethanolic NaOH afforded oxomaritidine 72 as a white powder in 65 % yield [69a] (Scheme 20). Reduction of 72 under Luche reduction [75] condition gave epi-maritidine (epi-2a), which upon mesylation followed by substitution using CsOAc and saponification gave maritidine 2a in 45 % yield (Scheme 20). The spectral data of 2a were found in good agreement with those of the reported one [68a] .
SYNTHESIS OF (±)-CRININE (2b)
After accomplishing the total synthesis of 2a, we focused toward synthesizing the (±)-crinine (2b). The crinine type of alkaloids elicits continued interest in the synthetic community owing in part to their intriguing physiological activities [5, 6] , as exemplified by the recent study unveiling highly selective apoptosis induction properties against tumor cells at as low as micromolar concentration. The crinine alkaloids are also shown to possess immunostimulant, antitumor, and antiviral activities [76] .
The synthesis of 2b was accomplished via the cycloaddition of 99 by following identical synthetic steps as described above for 2a (Scheme 20) . The stereochemistry of 102 was established by detailed COSY, NOESY, and HETCOR studies. The spectral data of 2b were found in good agreement with that of the reported one [68b].
